KPTI stock news · Karyopharm Therapeutics
Get alerts for KPTI
Follow Karyopharm Therapeutics (KPTI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for KPTI12 health care companies saw big changes in their stock prices after the market closed on Friday.
NeutralKaryopharm Therapeutics shares fell 8.1% in the after-market session. The article gives no company update, so it does not change the outlook for Karyopharm Therapeutics' business.
12 health care stocks changed a lot during Monday's after-hours trading.
NeutralThe article says Karyopharm Therapeutics shares rose about 8% after hours, but gives no company news explaining the move. The share-price change alone does not change its business outlook.
12 health care stocks are changing a lot during Wednesday's trading.
NeutralKaryopharm Therapeutics' shares fell 18.51% on Wednesday. The story gives no company update, so the move alone does not change the view of its business.
Karyopharm Therapeutics Inc. says it pushed back a deadline to October 22, 2026.
Bad for KPTIKaryopharm extended a temporary pause under its debt agreements by 7 days. The filing does not report a resolution, so the continuing debt strain weighs against the company.
12 health care stocks are changing a lot during Monday's trading.
NeutralKaryopharm Therapeutics shares fell 20.05% during Monday’s session, but the story gives no reason or company update. The price move alone does not change its business outlook.
12 health care companies saw big changes during Monday's trading.
NeutralKaryopharm Therapeutics' shares fell 20% on Monday. The story gives no company news to show that its business prospects changed.
Karyopharm Therapeutics Delivers Q2 2026 Results: Complete Earnings Call Transcript Available.
Bad for KPTIKaryopharm Therapeutics reported a decline in Q2 revenue, which may raise concerns among investors, but the company also reaffirmed its revenue guidance for 2026 and outlined strategic plans for its drug selinexor, indicating potential for future growth despite current challenges.